Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (5076)	5/24/1999 12:13:00 AM
From: Mad2	Respond to of 5736

Janybird...... Your correct in that I follow Mr. P$nks thread. Personally I have found that Mr. P$nk is excellent at what he does and that is pick stocks (long and short). I understand he doesn't have a position in CCSI at this time. None the less a poster by the handle of vampire piqued my interest here and if you or anyone else over here has a case for CCSI sucessfully marketing BiliTest to health care providers I'm interested in hearing it. From what I can tell BiliTest is CCSI's best shot at survival and their recent runup seems to have been based upon expectations of progress into this market. Certianly they are staffing for it, have spend over 1 million on machines in the past 3 months and have (according to the companies information) overcome the last hurdle towards marketing this device. I'm trying to decide if they have the wherewithall to actually have a chance at suceeding. The question in my mind (from my last post) is how are (or if) they going to get this device placed in a large number of facilities in a reasonable period of time? One answer is that a market doesn't exist for BiliTest and CCSI can't get more influencial distributers/health care marketers interested for that reason. Anyway it comes down dollars and cents. CCSI's filing's are not very helpful in that regard. They cite efforts with certian hospitals and their own personal additions however I can't see how those efforts are going to produce anything significant in the revenue area. I'm not trying to claim this view is correct (as I'm new to CCSI), rather I'm trying to findout what I'm missing as CCSI's valuation implies sucess in this area, yet they don't seem to have the marketing/sales infrastructure to acheive it. Mad2

To: JanyBlueEyes who wrote (5076)	5/24/1999 12:15:00 AM
From: BuzzVA	Respond to of 5736

Jany, Bad karma, in due time, will take care of those posters who infect this thread. All the money they make from their vile actions will not help them when bad karma pays them a visit. $4 to $12 is, in my book, a successful investment. Thanks to Mr. Fuchsia and his Power Rangers for playing the game. I always say, just use'em right back.

To: JanyBlueEyes who wrote (5076)	5/24/1999 12:20:00 AM
From: Robin	Respond to of 5736

Jany, So why is it you were quick to point out to 'Mad2' your colorful link to Med.Int., but failed to point out his/her error in assuming that last quarters revenues ($31K) were due to sales, not interest. Important Clarification to 'Mad2'; First quarter's sales totaled $100 only, the remaining $31K were due to interest for cash on hand, a number that is quickly declining, I might add (although the latest debenture/stock dilution should pump that number along with the faithful long here next quarter). So CCSI sold some lensettes and no units. Looks to me like they are getting off to a real slow start, which all have witnessed for the last two years. Also, noticed from the link that Med. Int. has 3 employees. My gosh, I'm starting to shake!!!! ROFLMAO!!!!! I wonder how many people are in the sales force for Healthdyne (who's product are they buying again?) Could there be more than three??? Naw!! Rockin' Robin